Search results for: “keytruda”
-
Media Room Article
Cancer Research Institute to Honor Three Scientists for Outstanding Contributions to Cancer Immunotherapy Research
CRI will bestow its highest honors on three scientists who have made seminal contributions to the fields…
-
Blog
Have an Autoimmune Disease? You Still May Be Able To Receive Cancer Immunotherapy
A retrospective study finds that immunotherapies are safe and work in many patients with preexisting autoimmune diseases.
-
Blog
The History and Future of Cancer Immunotherapy
The path to achieving immunotherapy’s full potential.
-
Blog
FDA Regulatory Definitions
You heard that a drug in clinical trials was Fast Tracked. Or you heard that a treatment…
-
Blog
Immunotherapy Approvals in 2015
In 2015, the FDA approved more immunotherapies than in any prior year.
-
Blog
Top 5 Cancer Immunotherapy Stories of 2015
Here’s what you, our online community, thought were the biggest stories of 2015.
-
Blog
Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer
New hope now exists for patients with advanced kidney cancer.
-
Blog
FDA Approves Expanded Use of Nivolumab for Lung Cancer
Nivolumab, a PD-1 immunotherapy, is now approved as second-line therapy for the most common type of lung…
-
Blog
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer
Patients with non-small cell lung cancer may now receive a PD-1 immunotherapy as second-line treatment after chemotherapy.